Fundraising FoxArgobiostudio
3 known investors
Find your way into Argobiostudio
Sign up to see every warm intro you have to Argobiostudio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Argobiostudio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Argobio is an operational venture builder in biotechnology sponsored by five strategic investors including venture capital and pharmaceutical partners. The company supports biotech innovation through partnerships with leading healthcare and research organizations.
Founders & leadership
YR
Yves RibeillPartner & EIRYves Ribeill founded and previously served as Chairman and CEO of SCYNEXIS, which he built through clinical development to a NASDAQ IPO. He spent a decade at Rhône-Poulenc and Aventis working on drug discovery and development, and currently serves as CEO of Enodia Therapeutics and Partner and Entrepreneur in Residence at Argobio Studio.
NM
Neill Moray MackenziePartner & EIRNeill Moray Mackenzie is a partner and EIR at Argobiostudio, a venture builder in biotechnology. He holds a PhD in molecular immunology from the University of Nottingham and has served as chief executive and board member across multiple biotech companies, with experience developing and commercializing biologics, small molecules, medical devices, and cell and gene therapies.
PS
Poul SørensenPartner & EIRPoul Sørensen holds a PhD in Biochemistry from Copenhagen University and serves as an Honorary Professor at Aarhus University. He has co-founded multiple biotechnology ventures and held leadership roles in company building, R&D, and business development, with expertise in neurology and inflammation & immunology.
Board
RS
Rémi SoulaPartner & EIR
Investors · 3
Kurma Partners✓ confirmed by ArgobiostudioParis · $162K – $10.8M
How we know: Kurma Partners's portfolio page · the company's own site · the VCSheet dataset · Not right? Tell us
Founder mafia
4 people who came through Argobiostudio went on to found or lead other companies.
Frequently asked questions
- What does Argobiostudio do?
- Argobio is an operational venture builder in biotechnology sponsored by five strategic investors including venture capital and pharmaceutical partners. The company supports biotech innovation through partnerships with leading healthcare and research organizations.
- Who are Argobiostudio's investors?
- Argobiostudio's investors include Kurma Partners, Angelini Ventures, Bpifrance.